-
Shortening the timeline for ALS treatments
https://braincanada.ca/about/news-updates/shortening-the-timeline-for-als-treatmentsDr. Carlos Rodrigo Camara-Lemarroy is an early-career researcher and clinical neurologist based in Canada at the University of Calgary. He is a first-time recipient of an ALS Canada-Brain Canada research grant. Can this routine and inexpensive procedure have a neuroprotective effect in ALS? Award:...
-
SHRF and Brain Canada announce partnership to invest in Saskatchewan Brain Health Solutions
https://braincanada.ca/about/news-updates/shrf-and-brain-canada-announce-partnership-to-invest-in-saskatchewan-brain-health-solutionsSaskatchewan Health Research Foundation (SHRF) and Brain Canada make a two-year commitment to fund Saskatchewan Brain Health research through SHRF’s Solutions Program. Brain Health is essential for physical health and a fundamental pre-requisite for mental health and well-being throughout our lives....
-
Signatures of early life stress as a risk factor for Alzheimer’s disease
https://braincanada.ca/funded-grants/signatures-of-early-life-stress-as-a-risk-factor-for-alzheimer-s-diseaseOur project investigates how childhood stress may increase the risk of developing Alzheimer’s Disease (AD) later in life. Project Overview Our project investigates how childhood stress may increase the risk of developing Alzheimer’s Disease (AD) later in life. We know that stress during early...
-
Significance of native PEG-PLGA nanoparticles in the treatment of Alzheimer’s disease pathology
https://braincanada.ca/funded-grants/significance-of-native-peg-plga-nanoparticles-in-the-treatment-of-alzheimer-s-disease-pathologyAt present, there is no effective treatment to arrest the progression of Alzheimer disease (AD) - the most common cause of dementia affecting the elderly. The disease is caused by accumulation of two distinct clumps of proteins in the brain called neuritic plaques and neurofibrillary tangles formed...
-
Significant funding boost for research on Alzheimer’s and ALS
https://braincanada.ca/about/news-updates/significant-funding-boost-for-research-on-alzheimer-s-and-alsDr. Meaghan O'Reilly, Sunnybrook Research Institute and the University of Toronto (left), and Dr. Liang Li, University of Alberta. Scientists from University of Toronto and University of Alberta, and their multinational teams, receive funding support from Brain Canada and CIHR Brain Canada and the...
-
Single-cell multi-omics to uncover mechanisms of patient glioblastoma heterogeneity and recurrence
https://braincanada.ca/funded-grants/single-cell-multi-omics-to-uncover-mechanisms-of-patient-glioblastoma-heterogeneity-and-recurrenceBrain cancer is rarely curative and urgently needs novel transformative treatments. Project Overview Brain cancer is rarely curative and urgently needs novel transformative treatments. Glioblastoma (GBM) is the most common primary malignant brain tumor in adults. It is also among the most...
-
Six early-career researchers receive leadership grants
https://braincanada.ca/about/news-updates/six-early-career-researchers-receive-leadership-grantsBrain Canada program supports paradigm-shifting neuroscience that improves the lives of Canadians Read the full article here.
-
SLAP-CAN In vivo Imaging Facility
https://braincanada.ca/funded-grants/slap-can-in-vivo-imaging-facilityThe central nervous system (CNS, the brain and spinal cord together) is perhaps the most complex biological entity in the world. Project Overview The central nervous system (CNS, the brain and spinal cord together) is perhaps the most complex biological entity in the world. The CNS allows us to...
-
Sleep, cognition, and inflammation following natural or surgical menopause
https://braincanada.ca/funded-grants/sleep-cognition-and-inflammation-following-natural-or-surgical-menopauseAlzheimer’s disease disproportionately affects women and emerging evidence suggests there may be unique biological and lifestyle factors that underlie these differences. Project Overview Alzheimer’s disease disproportionately affects women and emerging evidence suggests there may be unique...
-
Sneaking therapeutics into the brain
https://braincanada.ca/about/news-updates/sneaking-therapeutics-into-the-brainThese images were created by Dr. RosaNeto’s Lab at Douglas Hospital, McGill University and show the fusion between brain anatomy and amyloid deposition in the living human brain (top row) and rat (bottom row). There is no disease modifying molecule for Alzheimer’s disease currently on the market or...